Table 6.
Duration until return to normal temperature (efficacy population)
| Duration until ≤37.5°C (days) |
Total N = 2152 (100%) |
|||
|---|---|---|---|---|
| n* | (%) | n cum | (%) cum | |
| 1 |
273 |
(14.4)** |
273 |
(12.7) |
| 2 |
656 |
(34.6)** |
929 |
(43.2) |
| 3 |
557 |
(29.4)** |
1486 |
(69.1) |
| 4 |
214 |
(11.3)** |
1700 |
(79.0) |
| 5 |
116 |
(6.1)** |
1816 |
(84.4) |
| 6 |
30 |
(1.6)** |
1846 |
(85.8) |
| 7 |
27 |
(1.4)** |
1873 |
(87.0) |
| 8 |
7 |
(0.4)** |
1880 |
(87.4) |
| 9 |
5 |
(0.3)** |
1885 |
(87.6) |
| 10 |
8 |
(0.4)** |
1893 |
(88.0) |
| 11 |
2 |
(0.1)** |
1895 |
(88.1) |
| 20 |
1 |
(0.1)** |
1896 |
(88.1) |
| No return to normal T |
37 |
(1.7) |
1933 |
(89.8) |
| Patient not febrile at start |
189 |
(8.8) |
|
|
| T not taken continuously |
12 |
(0.6) |
|
|
| Missing |
19 |
(0.9) |
|
|
| Total | 2152 | (100.0) | 2152 | (100.0) |
*Multiple responses; **Percentage of total return to normal temperature (n = 1896).
T, temperature.